<DOC>
	<DOCNO>NCT00414778</DOCNO>
	<brief_summary>The purpose study evaluate safety pharmacokinetics single multiple dose LHT344 12 Chinese healthy subject . This study recruit subject United States .</brief_summary>
	<brief_title>Safety Pharmacokinetics LHT344 Chinese Healthy Subjects</brief_title>
	<detailed_description />
	<criteria>Healthy , nonsmoking , male female subject age 18 45 year age In good health confirm past medical history , physical examination , electrocardiogram , laboratory test urinalysis screen baseline evaluation Body mass index within range 19 24 kg/m2 weigh least 50 kg Smokers Use prescription drug within 4 week prior dose , overthecounter medication ( vitamin , herbal supplement , dietary supplement ) within 2 week prior dose . Paracetamol acceptable . Participation clinical investigation within 3 month prior dose . Donation loss 400 mL blood within 12 week prior first dose require local regulation . Significant illness within 2 week prior dose . A past personal close family medical history clinically significant cardiac abnormality myocardial infarction , angina , arterial fibrillation , arrhythmia hypertension . History fainting , low blood pressure upon stand , irregular heart beat acute chronic bronchospastic disease ( include asthma chronic obstructive pulmonary disease , treat treat ) . clinically significant drug allergy , history presence atopic allergy ( asthma , urticaria , eczematous dermatitis ) know hypersensitivity study drug similar drug surgical medical condition might significantly alter absorption , distribution , metabolism excretion drug may jeopardize subject participation study immunodeficiency disease , include positive HIV ( ELISA Western blot ) test result . positive Hepatitis B surface antigen ( HBsAg ) Hepatitis C test result . drug alcohol abuse within 12 month prior study participation Other protocoldefined inclusion/exclusion criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>January 2011</verification_date>
	<keyword>Safety , pharmacokinetics , oral , single dose , multiple dose , LHT344 , Chinese , healthy subject</keyword>
</DOC>